The Cancer Genome Atlas RNA-seq data show that LINC01314 is aberrantly expressed in various tumors, showing upregulation in thyroid carcinoma but downregulation in cholangiocarcinoma, esophageal carcinoma, kidney chromophobes, kidney renal papillary cell carcinoma, kidney carcinoma, lung adenocarcinoma, pheochromocytoma, and paraganglioma [12]. The gene discussed is CTXND1; the disease is renal carcinoma.